Skip to Content

Join the 'Vaccination' group to help and get support from people like you.

Vaccination News

Shingrix (zoster vaccine recombinant, adjuvanted) Approved in the U.S. for Prevention of Shingles

Posted 25 Oct 2017 by Drugs.com

London UK 20 October 2017 – GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 50 years and older. Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Dr. Thomas Breuer, Senior Vice ...

Seqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older

Posted 31 Aug 2016 by Drugs.com

CAMBRIDGE, Mass., Aug. 29, 2016 /PRNewswire/ – Seqirus announced today that the US Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in persons 18 years of age and older. Afluria Quadrivalent is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses ...

Sanofi Pasteur Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Children 4 through 6 Years of Age

Posted 25 Mar 2015 by Drugs.com

SWIFTWATER, Pa., March 25, 2015 /PRNewswire/ – Sanofi Pasteur, the vaccines division of Sanofi , announced today that the U.S. Food and Drug Administration (FDA) has approved use of Quadracel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Absorbed and Inactivated Poliovirus; DTaP-IPV) vaccine for active immunization against diphtheria, tetanus, pertussis and poliomyelitis in children 4 ...

New Bacterial Meningitis Vaccine Approved

Posted 26 Jan 2015 by Drugs.com

MONDAY, Jan. 26, 2015 – The Bexsero vaccine has been approved by the U.S. Food and Drug Administration to prevent the "serogroup B" form of bacterial meningitis among people aged 10 through 25. Meningococcal disease, or meningitis, is a life-threatening bacterial infection of the bloodstream and the lining that surrounds the brain and spinal cord. N. meningitis bacteria are commonly transmitted ...

FDA Approves Flublok - New Seasonal Influenza Vaccine Made Using Novel Technology

Posted 16 Jan 2013 by Drugs.com

January 16, 2013 – The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the prevention of seasonal influenza in people 18 through 49 years of age. Unlike current flu vaccines, Flublok does not use the influenza ...

Ask a Question